Berger MS - Search Results

1

Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.

Yu Y, Villanueva-Meyer J, Grimmer MR, Hilz S, Solomon DA, Choi S, Wahl M, Mazor T, Hong C, Shai A, Phillips JJ, Wainer BH, McDermott M, Haas-Kogan D, Taylor JW, Butowski N, Clarke JL, Berger MS, Molinaro AM, Chang SM, Costello JF, Oberheim Bush NA. Yu Y, et al. Among authors: berger ms. Neuro Oncol. 2021 Nov 2;23(11):1872-1884. doi: 10.1093/neuonc/noab081. Neuro Oncol. 2021. PMID: 33823014 Free PMC article.

2

Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies.

Le Roux PD, Berger MS, Wang K, Mack LA, Ojemann GA. Le Roux PD, et al. Among authors: berger ms. J Neurooncol. 1992 Jun;13(2):189-98. doi: 10.1007/BF00172770. J Neurooncol. 1992. PMID: 1432034

3

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure.

Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B. Spence AM, et al. Among authors: berger ms. J Neurooncol. 1992 Feb;12(2):187-91. doi: 10.1007/BF00172671. J Neurooncol. 1992. PMID: 1560266 Clinical Trial.

4

Neutron radiotherapy for malignant gliomas.

Griffin BR, Berger MS, Laramore GE, Griffin TW, Shuman WP, Parker RG, Davis LW, Diener-West M. Griffin BR, et al. Among authors: berger ms. Am J Clin Oncol. 1989 Aug;12(4):311-5. doi: 10.1097/00000421-198908000-00007. Am J Clin Oncol. 1989. PMID: 2547303 Review.

5

Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.

Hoyt JW, Gown AM, Kim DK, Berger MS. Hoyt JW, et al. Among authors: berger ms. J Neurooncol. 1995;24(2):163-9. doi: 10.1007/BF01078486. J Neurooncol. 1995. PMID: 7562003

6

The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Berger MS, Deliganis AV, Dobbins J, Keles GE. Berger MS, et al. Cancer. 1994 Sep 15;74(6):1784-91. doi: 10.1002/1097-0142(19940915)74:6<1784::aid-cncr2820740622>3.0.co;2-d. Cancer. 1994. PMID: 8082081

7

Pituitary oncocytomas: clinical features, characteristics in cell culture, and treatment recommendations.

Silbergeld DL, Mayberg MR, Berger MS, Ali-Osman F, Kelly WA, Shaw CM. Silbergeld DL, et al. Among authors: berger ms. J Neurooncol. 1993 Apr;16(1):39-46. doi: 10.1007/BF01324833. J Neurooncol. 1993. PMID: 8410141

8

Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.

Costello JF, Berger MS, Huang HS, Cavenee WK. Costello JF, et al. Among authors: berger ms. Cancer Res. 1996 May 15;56(10):2405-10. Cancer Res. 1996. PMID: 8625319

9

Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas.

Halligan JB, Stelzer KJ, Rostomily RC, Spence AM, Griffin TW, Berger MS. Halligan JB, et al. Among authors: berger ms. Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):541-7. doi: 10.1016/s0360-3016(96)80017-4. Int J Radiat Oncol Biol Phys. 1996. PMID: 8655378 Review.

10

Radical surgery in the management of low-grade and high-grade gliomas.

Rostomily RC, Keles GE, Berger MS. Rostomily RC, et al. Among authors: berger ms. Baillieres Clin Neurol. 1996 Jun;5(2):345-69. Baillieres Clin Neurol. 1996. PMID: 8781277 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

831 results

Search Page